BNR

About Burning Rock Biotech Limited American Depositary Shares (BNR) Stock

Burning Rock Biotech Limited American Depositary Shares (BNR) closed the 2026-09-18 session at $14.23, up 5.29% versus the previous close (+0.71). The stock opened at $13.45 and traded between $12.95 and $14.79 during that session. Session trading volume was 24K shares. The volume-weighted average price (VWAP) is $14.11.

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Burning Rock Biotech Limited American Depositary Shares has a market capitalization of $142.6 million. BNR is listed on the XNAS exchange. The company employs approximately 667 people. The recorded listing date is 2020-06-12.

On this page you can find market BNR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.